CE Activities
 | Novel Approaches for the Management of Elderly and Infirm Multiple Myeloma Patients CME, CPE, CNE Antonio Palumbo, MD and Sandra E. Kurtin, RN, MS, AOCN®, ANP-C | |
| Release Date: March 29, 2013 Expiration Date: March 29, 2014 | ||
| World-leading myeloma expert, Dr. Antonio Palumbo, describes strategies to tailoring therapy for specific elderly multiple myeloma patient needs, including recently proposed algorithms to assist in adjusting regimens as needed. Sandra Kurtin, nurse practitioner and assistant professor of clinical medicine and nursing at the University of Arizona further discusses special practice considerations including age, performance status, previous medical history, and tailoring supportive care based on patient specific risk factors for treatment associated side effects. Provided by MediCom Worldwide, Inc. This activity is supported by educational grants from Millennium: The Takeda Oncology Company and Celgene Corporation. | ||
| BeginView Only, No Credit | ||
 | Advances in Consolidation, Stem Cell Collection, and Transplantation CME, CPE, CNE Sergio Giralt, MD, and Beth Faiman, PhDc, RN, MSN, APRN-BC, AOCN® | |
| Release Date: March 15, 2013 Expiration Date: March 15, 2014 | ||
| Sergio Giralt, MD, and Beth Faiman, PhDc, RN, MSN, APRN-BC, AOCN®, navigate the management decision process for transplant-eligible patients, including tailoring treatment planning, establishing treatment goals, primary therapy choices, and addressing patient concerns as to whether autologous stem cell transplant is a necessity. Provided by MediCom Worldwide, Inc. This activity is supported by educational grants from Millennium: The Takeda Oncology Company and Celgene Corporation. | ||
| BeginView Only, No Credit | ||
 | The Multidisciplinary Team Approach: Managing the Newly Diagnosed Patient CME, CPE, CNE Sergio A. Giralt, MD, R. Donald Harvey III, PharmD, FCCP, BCPS, BCOP, and Beth Faiman, RN, MSN, APRN-BC, AOCN® | |
| Release Date: July 12, 2012 Expiration Date: July 12, 2013 | ||
| Join renowned multiple myeloma expert Sergio A. Giralt, MD, along with his colleagues R. Donald Harvey III, PharmD, FCCP, BCPS, BCOP, and Beth Faiman, RN, MSN, APRN-BC, AOCN® as they discuss the case of a newly diagnosed, transplant-eligible patient. This case will focus on considerations for management planning based on the patient’s medical history and comorbidities within the multidisciplinary setting. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Millennium: The Takeda Oncology Company | ||
| Begin | ||
 | Maintenance Therapy in the Management of Multiple Myeloma CME, CPE Antonio Palumbo, MD | |
| Release Date: March 15, 2012 Expiration Date: March 15, 2013 | ||
| Join Dr. Palumbo in a grand rounds discussion regarding maintenance therapy in the management of multiple myeloma. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Millennium: The Takeda Oncology Company | ||
| View Only, CE Expired | ||
 | Treatment Planning and Management of Relapsed/Refractory Multiple Myeloma CME, CPE David Siegel, MD, PhD | |
| Release Date: January 10, 2012 Expiration Date: January 10, 2013 | ||
| Join Dr. David Siegel in a grand rounds discussion regarding the treatment and management strategies for relapsed and refractory multiple myeloma. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Millennium: The Takeda Oncology Company. | ||
| View Only, CE Expired | ||
 | Newly Diagnosed, Elderly, Non-transplant Eligible Patient CME, CPE Adam D. Cohen, MD | |
| Release Date: November 01, 2011 Expiration Date: November 01, 2012 | ||
| Dr. Adam Cohen invites you to join him in a grand rounds discussion regarding approaches to tailoring induction and maintenance therapy for newly diagnosed, elderly (non-transplant eligible) multiple myeloma patients. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Millennium: The Takeda Oncology Company. | ||
| View Only, CE Expired | ||
 | Newly Diagnosed, Transplant Eligible Patient CME, CPE Edward A. Stadtmauer, MD | |
| Release Date: September 06, 2011 Expiration Date: September 06, 2012 | ||
| Dr. Edward Stadtmauer invites you to join him in a grand rounds discussion regarding approaches to tailoring induction therapy for newly diagnosed, transplant eligible multiple myeloma patients. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Millennium: The Takeda Oncology Company. | ||
| View Only, CE Expired | ||
 | Managing Oncologic Emergencies: Renal Failure, Hypercalcemia and Venous Thromboembolism in the Multiple Myeloma Patient CNE Kimberly Noonan, MS, RN, ANP, AOCN | |
| Release Date: July 29, 2011 Expiration Date: July 29, 2012 | ||
| Kimberly Noonan, MS, RN, ANP, AOCN, invites you to join her as she discusses the diagnosis, treatment, and risk-reduction of three common medical emergencies encountered in multiple myeloma patients: hypercalcemia, renal failure, and venous thromboembolism. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Millennium: The Takeda Oncology Company. | ||
| View Only, CE Expired | ||
 | Diagnosis, Staging, Risk Stratification, Prognosis and Response Assessment for the Newly Diagnosed MM Patient CME, CPE G. David Roodman, MD, PhD | |
| Release Date: July 05, 2011 Expiration Date: July 05, 2012 | ||
| In this first of a series of grand rounds presentations, widely recognized multiple myeloma (MM) expert Dr. G. David Roodman invites you to join him in discussions of a “real-world” newly diagnosed MM patient. The case focuses on clinical features, required diagnostic work-up, patient staging, and risk-stratification. It also addresses common comorbidities including treatment prioritization, goals, and patient response assessment according to International Myeloma Working Group (IMWG) universal response criteria. Whether you are new to myeloma or a seasoned professional, this presentation provides essential updates for today’s myeloma practitioner.
Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Millennium: The Takeda Oncology Company. | ||
| View Only, CE Expired | ||
 | Live from ASCO: Managing Myeloma Conference Highlights! CME | |
| Release Date: June 16, 2011 Expiration Date: June 16, 2012 | ||
| Dr. Kaufman leads a discussion with a panel of renowned experts reviewing the latest clinical trial results for multiple myeloma throughout the life cycle of the disease including their views regarding the implications for practice from the 2011 American Society of Clinical Oncology (ASCO) annual meeting, filmed live Sunday, June 5, 2011 in Chicago, Illinois. If you do not wish to earn CE credits for this activity but would like to view the highlight interviews, please click here. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant Millennium: The Takeda Oncology Company. | ||
| View Only, CE Expired | ||
 | Relapsed/Refractory Myeloma: Addressing the Challenge in 2011 CME, CPE, CNE Sergio A. Giralt, MD | |
| Release Date: February 21, 2011 Expiration Date: February 21, 2012 | ||
| Dr. Giralt discusses appropriate management strategies as well as emerging agents for the treatment of relapsed/refractory multiple myeloma.
Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Onyx Pharmaceuticals. | ||
| View Only, CE Expired | ||
 | Peripheral Neuropathy: Assessment and Management in the Multiple Myeloma Patient CNE Carol S. Viele, RN, MS, CNS , Sandra E. Kurtin, RN, MS, AOCN®, ANP-C | |
| Release Date: February 14, 2011 Expiration Date: February 14, 2012 | ||
| Carol Viele and Sandra Kurtin discuss the prevalence of peripheral neuropathy in patients with multiple myeloma and its management to preserve quality of life. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Millennium Pharmaceuticals, Inc. | ||
| View Only, CE Expired | ||
 | Considerations When Treating the Elderly Patient With Multiple Myeloma — A Case Study CME, CNE, CPE Sergio Giralt, MD, Contributing Author; Marie S. Recine, MS, Contributing Author | |
| Release Date: January 17, 2011 Expiration Date: January 17, 2012 | ||
| A case study following the treatment paradigm of an elderly, non–transplant-eligible patient with multiple myeloma.
Provided by MediCom Worldwide, Inc. This activity is supported by independent educational grants from Cephalon Oncology, and Millennium Pharmaceuticals, Inc. | ||
| View Only, CE Expired | ||
 | Tailored Pain Management Strategies for Multiple Myeloma Patients CNE Beth Faiman, RN, MSN, APRN-BC, AOCN®, April Hazard Vallerand, PhD, RN, FAAN | |
| Release Date: October 13, 2010 Expiration Date: October 13, 2011 | ||
| Beth Faiman and Dr. April Vallerand discuss the common causes and management of acute and chronic pain in multiple myeloma patients.
Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Millennium Pharmaceuticals, Inc. | ||
| View Only, CE Expired | ||
 | The Mastery of Myeloma Course CME, CNE, CPE Ann F. Mohrbacher, MD, James R. Berenson, MD , Ira Chang, MD, Thomas G. Martin, MD | |
| Release Date: March 08, 2010 Expiration Date: March 08, 2011 | ||
| Despite major advances in the treatment of multiple myeloma, practitioners continue to face challenges in formulating best strategies to treat patients with this disease. This series of CE case-based activities, adapted from the Mastery of Myeloma Course held in November 2009, will address appropriate practices in the multidisciplinary management of multiple myeloma for physicians, nurses, pharmacists, and physician assistants.
Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Millennium Pharmaceuticals, Inc. | ||
| View Only, CE Expired | ||
 | Approaches to Appropriate Treatment Sequencing in Multiple Myeloma CME Sagar Lonial, MD | |
| Release Date: June 26, 2009 Expiration Date: June 26, 2010 | ||
| In this program, Dr. Sagar Lonial will discuss therapeutic goals of induction therapy as well as the clinical evidence for various novel agent combinations in newly diagnosed transplant and non-transplant eligible multiple myeloma patients. He also discusses the goals and a number of treatment options, including novel combination therapies, for relapsed or refractory multiple myeloma including tailoring patient therapy according to previous clinical response as well as risk factors including age, renal impairment, and presence of comorbidities. | ||
| View Only, CE Expired | ||
 | Highlights of an ASH Symposium 2008 CME, CNE, CPE | |
| Release Date: June 30, 2009 Expiration Date: December 31, 2009 | ||
| This accredited symposium webcast titled, Emerging Standards of Care: Bringing Advances in Myeloma Therapy Into the Real World is sponsored by The CBCE™ (The Center for Biomedical Continuing Education). This activity in its current version is not commercially supported; however, the content was originally developed with support from Millennium Pharmaceuticals, Inc. | ||
| View Only, CE Expired | ||
 | Highlights From Therapeutic Advances in the Treatment and Management of MM CME, CNE, CPE Kenneth C. Anderson, MD, G. David Roodman, MD, PhD | |
| Release Date: December 06, 2008 Expiration Date: December 05, 2009 | ||
| This accredited symposium webcast is sponsored by The CBCE™ (The Center for Biomedical Continuing Education). This activity in its current version is not commercially supported; however, the content was originally developed with support from Millennium Pharmaceuticals, Inc. | ||
| View Only, CE Expired | ||
 | Forging Ahead for Optimal Management of Multiple Myeloma CNE | |
| Release Date: December 06, 2008 Expiration Date: December 05, 2009 | ||
| This program was originally presented as a live event. If you previously received credit for the live event, no further credit can be awarded for this web activity. This accredited slide audio activity is sponsored by Medical Education Resources, Inc. (MER). This activity is supported by an educational grant from Millennium Pharmaceuticals, Inc. | ||
| View Only, CE Expired | ||